Cyclin-dependent kinases at the G1-S transition of the mammalian cell cycle

Mutation Research - Reviews in Mutation Research

Volumn 436, Issue 1, 1999, Pages 1-9

  Hengstschläger, Markus ^a   Braun, Katja ^a   Soucek, Thomas ^a   Miloloza, Angelina ^a   Hengstschläger Ottnad, Elke ^b  

^a U ^*  (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cdk3; Cdks; Cell cycle; Replication

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN E; CYCLINE;

CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELLULAR DISTRIBUTION; DNA REPLICATION; MAMMAL CELL; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW;

MAMMALIA; XENOPUS;

EID: 0345435117     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(98)00022-2     Document Type: Article

References (62)

1. Morgan D.O. Principles of CDK regulation. Nature. 374:1995;131-134.
2. Draetta G.F. Will the real Cdk-activating kinase please stand up. Curr. Biol. 7:1997;R50-R52.
3. Bates S., Parry D., Bonetta L., Vousden K., Dickson C., Peters G. Cdk6 (PLSTIRE) and Cdk4 (PSK-J3) are distinct subset of the cyclin-dependent kinases that associate with cyclin D1. Oncogene. 9:1994;71-79.
4. Kato J.H., Matsushime H., Hiebert S.W., Ewen M.E., Sherr C.J. Direct binding of cyclin D to the retinoblastoma product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:1993;331-342.
5. Meyerson M., Harlow E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:1994;2077-2086.
6. Dulic V., Lees E., Reed S.I. Association of human cyclin E with a periodic G1-S phase protein kinase. Science. 257:1992;1958-1961.
7. Koff A., Giordano A., Desai D., Yamashita K., Harper J.W., Elledge S., Nishimoto T., Morgan D.O., Franza R.B., Roberts J.M. Formation and activation of a cyclin E-Cdks complex during the G1 phase of the human cell cycle. Science. 257:1992;1689-1694.
8. Pines J., Hunter T. Human cyclin A is adenovirus E1A-associated p60 and behaves differently from cyclin B. Nature. 346:1990;760-763.
9. van den Heuvel S., Harlow E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science. 262:1993;2050-2054.
10. Hofmann F., Livingston D.M. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit. Genes Dev. 10:1996;851-861.
11. Meyerson M., Enders G.H., Wu C.-L., Su L.-K., Gorka C., Nelson C., Harlow E., Tsai L.-H. A family of human cdc2-related protein kinases. EMBO J. 11:1992;2909-2917.
12. Harper J.W., Elledge S.J., Keyomarsi K., Dynlacht B., Tsai L.-H., Zhang P., Dobrowolski S., Bai C., Connell-Crowley L., Swindell E., Fox M.P., Wei N. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell. 6:1995;387-400.
13. Connell-Crowley L., Harper J.W., Goodrich D.W. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol. Biol. Cell. 8:1997;287-301.
14. K. Braun, G. Hölzl, T. Soucek, C. Geisen, T. Möröy, M. Hengstschläger, Investigation of the cell cycle regulation of Cdk3-associated kinase activity and the role of Cdk3 in proliferation and transformation, Oncogene (16) (1998), in press.
15. Steiner P., Philipp A., Lukas J., Godden-Kent D., Pagano M., Mittnacht S., Bartek J., Eilers M. Identification of a Myc-dependent step during formation of active G1 cyclin-cdk complexes. EMBO J. 14:1995;4814-4826.
16. Pusch O., Bernaschek G., Eilers M., Hengstschläger M. Activation of c-Myc uncouples DNA replication from activation of G1-cyclin-dependent kinases. Oncogene. 15:1997;649-656.
17. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163.
18. Harper J.W., Elledge S.J. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6:1996;56-64.
19. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9:1995;650-662.
20. Pines J. Cyclins and cyclin-dependent kinases: a biochemical view. Biochem. J. 308:1995;697-711.
21. Nigg E.A. Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. BioEssays. 17:1995;471-480.
22. Alessandrini A., Chiaur D.S., Pagano M. Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation. Leukemia. 11:1997;342-345.
23. Diehl J.A., Zindy F., Sherr C.J. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11:1997;957-972.
24. Clurman B.E., Sheaff R.J., Thress K., Groudine M., Roberts J.M. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev. 10:1996;1979-1990.
25. Won K.A., Reed S.I. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J. 15:1996;4182-4193.
26. Townsley F.M., Ruderman J.V. Proteolytic ratchets that control progression through mitosis. Trends Cell Biol. 8:1998;238-244.
27. E.R. Kramer, C. Gieffers, G. Hölzl, M. Hengstschläger, J-M. Peters, Activation of the human anaphase promoting complex by proteins of the CDC20/Fizzy family, Curr. Biol. (1998), in press.
28. Nevins J.R. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science. 258:1992;424-429.
29. Lam E.W.F., LaThangue N.B. DP and E2F proteins: coordinating transcription with cell cycle progression. Curr. Opin. Cell. Biol. 6:1994;859-866.
30. Helin K. Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. Dev. 8:1998;28-35.
31. Morkel M., Wenkel J., Bannister A.J., Kouzarides T., Hagemeier C. An E2F-like repressor of transcription. Nature. 390:1997;567-568.
32. Trimarchi J.M., Fairchild B., Verona R., Moberg K., Andon N., Lees J.A. E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc. Natl. Acad. Sci. USA. 95:1998;2850-2855.
33. Cartwright P., Müller H., Wagener C., Holm K., Helin K. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene. 17:1998;611-624.
34. Planas-Silvam M.D., Weinberg R.A. The restriction point and control of cell proliferation. Curr. Opin. Cell Biol. 9:1997;768-772.
35. Schulze A., Zerfass K., Spitkovsky D., Middendorf S., Berges J., Helin K., Jansen-Dürr P., Henglein B. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc. Natl. Acad. Sci. USA. 92:1995;11264-11268.
36. Ohtani K., DeGregori J., Nevins J.R. Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. USA. 92:1995;12146-12150.
37. DeGregori J., Kowalik T., Nevins J.R. Cellular targets for activation by the E2F-1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol. 15:1995;4215-4224.
38. Geng Y., Eaton E.N., Picon M., Roberts J.M., Lundberg A.S., Gifford A., Sardet C., Weinberg R.A. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene. 12:1996;1173-1180.
39. Botz J., Zerfass-Thome K., Spitkovsky D., Delius H., Vogt B., Eilers M., Hatzigeorgiou A., Jansen-Dürr P. Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol. Cell. Biol. 16:1996;3401-3409.
40. Shan B., Farmer A.A., Lee W.-H. The molecular basis of E2F/DP-1-induced S-phase entry and apoptosis. Cell Growth Differ. 7:1996;689-697.
41. Soucek T., Pusch O., Hengstschläger-Ottnad E., Adams P.D., Hengstschläger M. Deregulated expression of E2F-1 induces cyclin A- and E-associated kinase activities independently from cell cycle position. Oncogene. 14:1997;2251-2257.
42. Khleif S.N., DeGregori J., Yee C.L., Otterson G.A., Kaye F.J., Nevins J.R., Howley P.M. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc. Natl. Acad. Sci. USA. 93:1996;4350-4354.
43. Watanabe G., Albanese C., Lee R.J., Reutens A., Vairo G., Henglein B., Pestell R.G. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol. Cell. Biol. 18:1998;3212-3222.
44. Lukas J., Herzinger T., Hansen K., Moroni M.C., Resnitzky D., Helin K., Reed S.I., Bartek J. Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev. 11:1997;1479-1492.
45. Leng X., Connell-Crowley L., Goodrich D., Harper J.W. S-phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation. Curr. Biol. 7:1997;709-712.
46. Quelle D.E., Ashmun R.A., Shurtleff S.A., Kato J., Bar-Sagi D., Roussel M.F., Sherr C.J. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 7:1993;1559-1571.
47. Ohtsubo M., Roberts J.M. Cyclin-dependent regulation of G1 in mammalian cells. Science. 259:1993;1908-1912.
48. Resnitzky D., Gossen M., Bujard H., Reed S.I. Acceleration of the G1/S phase transition by expression of cyclin D1 and E with an inducible system. Mol. Cell Biol. 14:1994;1669-1679.
49. Resnitzky D., Reed S.I. Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol. Cell Biol. 15:1995;3463-3469.
50. KIP1. Mol. Cell Biol. 15:1995;4347-4352.
51. Rosenberg A.R., Zindy F., LeDeist F., Mouly H., Metezeau P., Brechot C., Lamas E. Overexpression of human cyclin A advances entry into S phase. Oncogene. 10:1995;1501-1509.
52. Connel-Crowley L., Elledge S.J., Harper J.W. G1 cyclin-dependent kinases are sufficient to initiate DNA synthesis in quiescent human fibroblasts. Curr. Biol. 8:1998;65-68.
53. Stillman B. Cell cycle control of DNA replication. Science. 274:1996;1659-1664.
54. K. Nasmyth, Control of S phase, in: M.L. DePamphilis (Ed.), DNA Replication of Eukaryotic Cells, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, pp. 331-386.
55. Donavan S., Harwood J., Drury L.S., Diffley J.F.X. Cdc6-dependent loading of Mcm proteins onto pre-replicative chromatin in budding yeast. Proc. Natl. Acad. Sci. USA. 94:1997;5611-5616.
56. Aparicio O.M., Weinstein D.M., Bell S.P. Components and dynamics of DNA replication complexes in S. cerevisiae: redistribution of MCM proteins and Cdc45p during S phase. Cell. 91:1997;59-69.
57. Tanaka T., Knapp D., Nasmyth K. Loading of Mcm protein onto DNA replication origins is regulated by Cdc6p and CDKs. Cell. 90:1997;649-660.
58. Liang C., Stillman B. Persistent initiation of DNA replication and chromatin-bound MCM proteins during the cell cycle in cdc6 mutants. Genes Dev. 11:1997;3375-3386.
59. Jallepalli P.V., Kelly T.J. Cyclin-dependent kinase and initiation at eukaryotic origins: a replication switch? Curr. Opin. Cell. Biol. 9:1997;358-363.
60. Yan Z., DeGregori J., Sohet R., Leone G., Stillman B., Nevins J.R., Williams S.R. Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. Proc. Natl. Acad. Sci. USA. 95:1998;3603-3608.
61. Saha P., Chen J., Thome K.C., Lawlis S.J., Hou Z.-H., Hendricks M., Parvin J.D., Dutta A. Human CDC6/Cdc18 associates with Orc1 and Cyclin-cdk and is selectively eliminated from the nucleus at the onset of S phase. Mol. Cell. Biol. 18:1998;2758-2767.
62. INK4 as upstream regulators of Myc. Oncogene. 15:1997;179-192.